Clinical Trials Directory

Trials / Completed

CompletedNCT04762706

Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.

Treating the Whole Patient: Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
West Virginia University · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether patients being treated for prosthetic joint infections (PJI) experience distress during the course of their treatment and how distress influences various aspects of their lives. WVU expects to enroll approximately 12 subjects. Patients identified as scoring ≥4 on the Distress Thermometer at the two-week follow-up visit will be offered the opportunity to participate in the novel CRUTCH Pathway. Once enrolled, you will meet virtually with a mental health provider. The mental health provider will complete a 30-minute intake visit where he will review your distress thermometer scoring, discuss contributing factors to current distress level, and assess for psychiatric comorbidities.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCRUTCH PathwayPatients will be offered referral to a behavioral medicine specialist in the novel Combined Rehabilitation Using Team Centered Help (CRUTCH) Pathway. Once enrolled, these patients will meet virtually with a psychiatrist. The psychiatrist will complete a 30-minute intake visit where he will review the patient's DT scoring, discuss contributing factors to current distress level, and assess for psychiatric comorbidities. Following this assessment, psychotherapy, psychotropic medication, and referral for social work/financial services will be offered to the patient as indicated. If more frequent behavioral health follow-up is clinically indicated, it will be provided to the patients.

Timeline

Start date
2021-03-04
Primary completion
2024-01-01
Completion
2024-07-01
First posted
2021-02-21
Last updated
2024-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04762706. Inclusion in this directory is not an endorsement.